Clinical study for high expression of NOX4 in gallbladder carcinoma and its mesenchym to predict poor prognosis of gallbladder carcinoma patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023315

Enrollment

Unknown

Registered

2019-05-22

Start date

2019-07-01

Completion date

Unknown

Last updated

2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gallbladder carcinoma

Interventions

Case series:No intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gallbladder carcinoma patients with surgical resection and pathological diagnosis, and without preoperative chemotherapy, or non-surgical gallbladder carcinoma patients without chemotherapy clinically diagnosed by b-ultrasound, CT and serum tumour mark

Exclusion criteria

Exclusion criteria: Surgical resection gallbladder carcinoma patients with pathological diagnosis and preoperative chemotherapy, or non-surgical gallbladder carcinoma patients with chemotherapy clinically diagnosed by b-ultrasound, CT and serum tumour mark

Design outcomes

Primary

Measure	Time frame
NOX-4(NADPH oxidase 4, nicotinamide adenine dinucleotide phosphate oxidase 4);	—

Countries

China

Contacts

Public ContactZhang Jingtao

Shanghai Tongji Hospital of Tongji University

drzhangjingtao826@aliyun.com+86 13524143092

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026